VOYA Investment Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
FCM
AIM
AVM
NAMA
VOYA Investment Management's BEAM Position: Q2 2026 in Review
VOYA Investment Management increased its Beam Therapeutics (BEAM) stake by 67% in Q2 2026, buying an estimated $842K and bringing the position to 69,375 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1161.
VOYA Investment Management first reported a position in BEAM in Q3 2020 and has held it in 24 quarters since. The position peaked at $12.9M in Q3 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.
- VOYA Investment Management held 69,375 shares of Beam Therapeutics worth $2.38M as of Q2 2026.
- VOYA Investment Management bought 27,882 Beam Therapeutics shares in Q2 2026, an estimated $842K.
- Beam Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1161 holding.
- VOYA Investment Management first reported a position in Beam Therapeutics in Q3 2020 and has held it in 24 quarters since.
- VOYA Investment Management's Beam Therapeutics position peaked at $12.9M in Q3 2021.
- 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.
Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.